课题基金 / 基金详情

The Risk of Pulmonary Embolism and Deep Vein Thrombosis in Major Rheumatic Disorders

The Risk of Pulmonary Embolism and Deep Vein Thrombosis in Major Rheumatic Disorders
主要风湿性疾病中肺栓塞和深静脉血栓形成的风险
批准号：
268137
负责人：
Avina-Zubieta Juan A
金额：
$10.72万
依托单位：
Arthritis Research Centre Society of Canada (British Columbia)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2012
资助国家：
加拿大
项目状态：
已结题
起止时间：
2012-09-01 至 2014-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=268137&lang=en
关键词：
Administrative Health Data Arthritis Cardiovascular Co-Morbidity Mortality Population-Based Prevention Interventions Public Health Rheumatic Diseases Risk

项目摘要

项目成果

Avina-Zubieta Juan A的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Due to persistent inflammation, people with arthritis are at risk of developing cardiovascular complications, which are the primary cause of premature death in this population. VTE is a form of cardiovascular condition that causes blood clots in deep vein
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Towards Improving Screening of Retinal Toxicity of Hydroxychloroquine in patients with Systemic Lupus Erythematosus (SLE) and Rheumatoid Arthritis (RA).
  • 批准号：
    404423
  • 项目类别：
    Miscellaneous Programs
  • 资助金额：
    $0.73万
  • 财政年份：
    2019
  • 负责人：
    Avina-Zubieta Juan A
  • 依托单位：
    University of British Columbia
Risk of Retinal Toxicity in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis on Long-term Hydroxychloroquine Therapy
  • 批准号：
    389090
  • 项目类别：
    Operating Grants
  • 资助金额：
    $51.55万
  • 财政年份：
    2018
  • 负责人：
    Avina-Zubieta Juan A
  • 依托单位：
    University of British Columbia
Using Administrative, Electronic Medical Record and Patient Health Record Data in Clinical Trials
  • 批准号：
    348661
  • 项目类别：
  • 资助金额：
    $0.2万
  • 财政年份：
    2015
  • 负责人：
    Avina-Zubieta Juan A
  • 依托单位：
    University of British Columbia
国内基金
海外基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data